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Abstract: Infectious diseases are the leading cause of morbidity and mortality in low and middle
income countries (LMICs). Rapid diagnosis of infections in LMICs presents many challenges,
especially in rural areas where access to health care, including diagnostics, is poor. Microscopy
is one of the most commonly used platforms to diagnose bacterial infections on clinical samples.
Fluorescence microscopy has high sensitivity and specificity but to date is mostly performed
within a laboratory setting due to the high-cost, low portability and highly specialist nature of
equipment. Point-of-care diagnostics could offer a solution to the challenge of infection diagnosis
in LMICs. In this paper we present frugal, easy to manufacture, doped polydimethylsiloxane
filtering optical lenses that can be integrated into smartphone microscopes for immediate
detection of fluorescently labelled bacteria. This provides a breakthrough technology platform
for point-of-care diagnostics.
Published by The Optical Society under the terms of the Creative Commons Attribution 4.0 License. Further
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1. Introduction
Sepsis and other bacterial infections are a leading cause of mortality globally, with the greatest
burden affecting low and middle income countries (LMICs) [1]. Point-of-care (POC) diagnostics
will enable faster decision making and timely treatments [2]. However, diagnosing infections in
low resource settings presents many challenges which include technological and infrastructural
limitations alongside integration into care pathways [1–3].
In the absence of bacteriological confirmation many infections are treated empirically, which
can add to the global issue of antimicrobial resistance [4]. Some diagnoses, such as the initial
screening for suspectedMycobacterium tuberculosis (Mtb), are heavily reliant on benchtop ex
vivomicroscopy. In this case, a technician must prepare and examine each individual sample slide
to confirm the presence of a microorganism in a sample. The specificity and sensitivity of these
tests is known to vary between 20 - 80% [5], with technician fatigue and experience impacting
the outcome [5–7]. Indeed, sputum smear microscopy is the cornerstone of tuberculosis (TB)
screening and identifies patients who may be infectious and a public health risk. Despite decades
of progress in microscopy, smear microscopy remains a laboratory based process with slow
turnaround and high resource requirements of trained staff [8]. The END TB initiative highlights
the need for POC diagnostics and is key to reducing mortality [9].
Molecular-based fluorescent labels have the potential to lessen these requirements by increasing
the specificity and sensitivity through increasing signal to noise ratios. However, it is not yet
readily possible to use current benchtop fluorescence microscopes outside of the laboratory
setting [10]. The microscope optics, both for white-light and fluorescence modalities, present a
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significant POC translational challenge. They often require expensive, specialized light sources,
optics, and sensors and need additional power sources [10,11].
Developments have been made to address the need for lower cost, more accurate diagnostics
in LMICs. Since the 2000s, complementary metal-oxide-semiconductor (CMOS) sensors have
become an enabling technology due to their widespread employment in smartphones [12,13].
Today, CMOS sensors permit miniaturization, require less power, are inexpensive, and are readily
available which has opened up their use as diagnostic devices at the POC [14–16]. Smartphones or
other mobile devices, and single-board computers such as the raspberry Pi have combined sensors
and communication tools including wireless internet (WiFi) and Bluetooth [17]. The advanced
data compression functionality of CMOS sensors and the potential of mobile applications will
allow in situ or remote diagnostics at an accurate level [18,19]. For LMICs, lower cost LED
microscopy offers an alternative to expensive laser diode microscopes used in higher income
countries [20].
In a fluorescence microscope an emission filter is used to block illumination light, allowing
only the emitted fluorescence from the sample to be transmitted to the detector, increasing signal
to noise ratio. Long pass filters are commonly used in fluorescence microscopy systems [21].
However, these components occupy valuable and limited space which can be a problem in a
space-constrained handheld system where the lenses require a short focal length. Furthermore,
the associated costs of multiple components can be prohibitively high [11]. In terms of sample
preparation, recent chemical innovation has led to targeted ‘smart’ fluorescent stains that need
little processing, acting as a switch when they come into contact with a bacterial cell membrane
[22–24]. These labels may have major utility in settings where time and resources are limited
such as in rural LMICs.
Cheaper optical components, including polydimethylsiloxane (PDMS) lenses have been
developed and combined with smartphones [25,26]. PDMS has good optical characteristics such
as transparency (T= 90 - 95%) [25,27] and is heat curable, meaning that it is possible to control
its curing curvature, and thus the focal length of the lens. Previous work has indicated that for
10 µL heat cured PDMS lenses, a temperature of 200 °C gives rise to the greatest contact angle
and magnification [25]. Additionally, this lens offers sufficient resolution for histological [25]
and bacteriological imaging [21,28]. Smartphone microscopy systems have been developed with
a resolution compatible with viruses and 100 nm nanoparticles, yet the use of laser diode light
sources and expensive external lenses [29] may make cost a prohibitive factor for translation to a
low resource setting. Low cost 3D printable structures including accurate stages could be used as
a framework for any future imaging platform [30].
Here, we describe how a PDMS integrated filtering lens (IFL) doped with a silicone dye is able
to act as both an emission filter and a lens for use at the POC. It has suitable imaging characteristics
for detection of fluorescently labelled Mycobacteria smegmatis (a rare human-pathogen but
commonly used as a laboratory model for Mtb) [31,32]. The IFLs negate the need for two
separate components in a POC device, which has the advantage of reducing the required physical
space in any device. At a cost of less than 0.02 USD per lens, these IFLs could contribute towards
low cost POC diagnostic solutions.
2. Material and methods
In order to fully characterize the IFLs, both the filtering properties and imaging properties of
the lenses were tested, before being demonstrated in conjunction with a smartphone to image
fluorescently labelled M. smegmatis. The following sections describe: the methodology for
manufacturing the PDMS IFLs (Sec. 2.1); characterization of the imaging and filtering properties
of PDMS lenses (Sec. 2.2); and the fluorescent M. smegmatis slide preparation (Sec. 2.3).
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2.1. PDMS filtering lens manufacture
PDMS solution (Sylgard 184, Merck) was mixed in manufacturer’s guidelines 10:1 of polymer to
curative agent. Additionally, green or red silicone dye (Silc Pig Green or Red, Bentley Advanced
Materials) was added to 1%, 3%, 5%, 7% or 10% by weight to the polymer mix. This was then
vacuum degassed to remove bubbles and ensure overall good imaging quality through the lens.
10 µL or 25 µL of polymer was syringed onto a clean glass slide on a heat plate at a range of
temperatures from 150 °C to 225 °C.
2.2. Filtering and imaging characterization of PDMS filtering lenses
2.2.1. Setup for transmission measurement
The filtering effect of the lens with added dye was tested by placing the lens in the optical path of
a white light source. The light source was collimated and the spot minimized using an iris before
passing through the filtering lens which focused it into the spectrometer (USB2000+, Ocean
Optics).
2.2.2. Optical setup for lens focal length
To test the effect of the doping on the focal length of the lens, a 505 nm fibre coupled LED
(M505F3, Thorlabs) setup was used. This incident light was collimated using a lens (C330TMD-
A, Thorlabs) and minimized using an iris (SM1D12D, Thorlabs). A CMOS camera (DCC1645C,
Thorlabs) was placed on a micrometer stage (XR50C/M, Thorlabs) so that the focal length of the
lens could be calculated by finding the smallest spot size on the camera.
2.2.3. Measurement of filtering lens contact angle
To measure the contact angle of each lens, a OnePlus 5 T smartphone (android 9) camera (16MP)
was positioned fixed to the normal of the glass slide in a slide holder (XYF1/M, Thorlabs). The
filtering lens was on the superior surface of the glass slide. Images were taken at maximum zoom
(x8). Image analysis was performed using Fiji_64 Image J contact angle plug-in.
2.2.4. Optical setup for resolution imaging
The imaging capabilities were tested using a white LED light source to illuminate a positive 1951
USAF resolution target for non-fluorescence imaging (R1DS1P, Thorlabs). The target was placed
at the focal length of the filtering lens which was placed on the front camera of the OnePlus 5 T
smartphone.
2.3. Fluorescent mycobacterial slide preparation
M. smegmatis (ATCC 23032) colonies were grown on 7H10 Middlebrook agar (Merck, catalogue
M0303) supplemented with 10% v/v oleate-albumin-dextrose-catalase (OADC) (Merck cat.
M0678), 0.5% glycerol (Merck, catalogue G5516) and sodium pyruvate (Merck, catalogue
5280) at 37 °C and stored at 4 °C. A single colony was smeared directly into an ‘all microbe’,
NBD-based SmartProbe (30 µL, 5 µM) [22] on a clean glass microscope slide and mounted with
a coverslip. Images were captured using the smartphone-IFL device setup as described above, or
by wide-field microscopy (EVOS FL Imaging System, Thermo Scientific AMF4300) with GFP
LED filter cube and 20x objective. Images were brightness and contrast enhanced using Fiji_64
Image J.
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3. Results and discussion
3.1. Characterization of the filtering lenses
To investigate the effect of adding in a silicone pigment to the clear PDMS lens, fabrication for
the 25 µL lenses occurred over a temperature range from 150 °C to 225 °C, and across a range of
doping from 0% to 10% as shown in Fig. 1(A). Additionally, 10 µL lenses were fabricated at 225
°C. The average usable diameter, or clear aperture, was calculated using the lens on a CMOS
detector. As expected, the larger (25 µL) lens has a greater clear aperture which gives a larger
field-of-view (FOV).
Previous work from Sung et al. [25] demonstrated that the focal length, f, of clear PDMS
lenses reduces with increasing temperature. Here, we observed that at temperatures of > 200
°C there was a plateauing of the focal length suggesting that for the 25 µL lenses there was a
minimal achievable focal length (Fig. 1(D)). To compare the effect of volume on focal length,
the 10 µL lenses fabricated at 225 °C were compared to the 25 µL lenses fabricated at the same
temperature. The focal length of the 10 µL lenses was approximately half the focal length of the
25 µL lenses (Fig. 1(E)).
By comparing the 0% (i.e. clear) doped lenses, with 3% and 10% lenses it was found that
the dye had no effect on the focal length of the lenses shown in Fig. 1(D), with there being no
significant differee between any of the doping concentrations.
The focal length and temperature correlate as a result of the variation in the contact angle
created at these temperatures. The PDMS cures more quickly at higher temperature and so gravity
has less opportunity to take effect, resulting in a greater contact angle. The doping percentage of
the PDMS lenses did not have an effect on the contact angle, shown in Fig. 2(A). There was no
significant difference in contact angles between the 10 µL and the 25 µL lenses fabricated at 225
°C suggesting that at this temperature contact angle is independent of volume. Figure 2(B) shows
correlation between contact angle and focal length. At a focal length of 6mm, there is a greater
range of contact angles than for higher focal lengths such as 10mm.
The focal length of a lens is proportional to its radii of curvature and is expressed by the
lensmaker’s equation. Taking the thin lens approximation,
1
f
≈
n2 − n1
n1
(
1
R1
−
1
R2
)
, (1)
where n1 and n2 are the refractive indices of air and PDMS, respectively, and R1 and R2 are the
radii of curvature of the two surfaces. In the case of planar convex lenses, such as the PDMS
IFLs, the term 1/R1 vanishes and the formula can be rearranged to express R2 as,
R2 ≈ 0.4f , (2)
where we have taken the refractive index of PDMS to be 1.4. R2 decreases with temperatures
from 150 °C to 200 °C and then plateaus from 200 °C to 225 °C shown in Fig. 2. The 10 µL
lenses have a smaller R2 than the 25 µL lenses.
Figure 2(C) shows correlation between temperature and relative curvature (R) of the lenses.
At the highest temperatures, there is greater variation in R, causing variation in focal length
(observed in Fig. 2(B)), even though contact angle is repeatable.
It may be that contact angles are approaching a maximum achievable at high temperatures
while R is still varying, however further work would need to investigate higher temperatures to
clarify this. The contact angle will also be influenced by the drop height. There may have been an
error introduced in fabrication with drop height only controlled to the nearest 5mm. Additionally,
the heat plate may not be of uniform heat across the surface and so the positioning of the glass
slide during manufacture may have resulted in a slight spatial variation in temperature. This
could have contributed to a slight variation in diameter/contact angle at each volume/temperature
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Fig. 1. The doping in the PDMS lenses does not affect the ability for the lens to focus light.
(A) Hand syringed filtering 25 µL PDMS lenses doped with green silicone pig dye at 0%,
1%, 3%, 5%, 7% and 10% by weight as shown in each row. The lenses were fabricated at
increasing temperatures as shown in each column with 150 °C on the left, increasing to 225
°C on the right. (B) The usable diameter/clear aperture of the 10 µL and 25 µL lenses is
1.03mm and 1.85mm, respectively, as measured using Image J. (C) Focal length schematic
showing LED light source attached to optical fibre with a collimating lens (L1), iris and
PDMS lens (LPDMS). The camera is mounted onto a z-stage and attached to the computer.
(D) With increasing temperature the focal length of the lenses reduced. The doping has no
effect on the behavior of the lens with the 0%, 3% and 10% behaving with a similar pattern.
Data shown for 25 µL lenses, with each lens shown by a single point. (E) The lower volume
lenses (10 µL) have a smaller focal length than the larger 25 µL lenses, with the doping
having little effect on the behavior of the lens. Each point represents a single filtering lens
manufactured at 225 °C.
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Fig. 2. Adding a doping dye to the PDMS lenses does not alter geometry of the lens. The
contact angles relative curvature were measured using the Image J plug-ins. (A) With
increasing temperature the contact angle increased for the 25 µL lenses. The doping has no
effect on the contact angle on the lens with the lenses within each temperature grouping
having similar contact angle. Each point represents the average contact angle of three
separate lenses, manufactured at a given temperature and doping, with error bars showing
the s.e.m. (B) The contact angle correlates with the focal length, with greater variation at
lower focal lengths. Doping the lens does not affect this trend. Each point represents a single
lens with n= 3 IFLs measured for each temperature. (C) The relative curvature (R) of the
lenses (proportional to the focal length) is dependent on temperature. The 10 µL lenses have
a lower R. The doping has no effect on R. Each point is represented by the average of three
lenses with error bars denoting the s.e.m of the group.
combination. Damodroa [27] found a similar effect to that observed here, with both f -number
and NA being independent of temperature above a certain temperature (for 3 µL lenses this was
98 °C).
The doping is considered to have no effect on the curvature of the lens. This is important
as the curvature of the lens will affect the NA. The NA of 0.27 is based on the usable radius
of 1.03mm and 1.86mm for the 10 µL and 25 µL lenses, respectively. This is in keeping with
previous work [25,27].
3.2. The PDMS integrated filtering lenses transmit in a concentration dependent
manner
The purpose of doping the lens is to enable one component to act as both an emission filter and a
lens. The filtering properties of the IFL need to behave in two ways; i) to block the incident light
(excitation wavelength in the fluorescence system) and ii) to transmit the emitted light.
When green IFLs are compared to red IFLs and a clear PDMS lens, the ability to transmit/absorb
light based on a specific wavelength becomes clear, as shown in Fig. 3(B). The red IFLs do not
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transmit green wavelengths whereas the green IFLs do, and the clear lens is able to transmit
light across the wider visible spectrum. The percentage of doping in the green IFLs effects the
transmission of light across the green wavelengths of light. The lower doping (1% and 3%)
enable a higher percentage of transmission than higher doping (7% and 10%), allowing more of
the fluorescence light to reach the detector in a fluorescence system. Therefore the lower doped
IFLs are better at this behaviour (described as behavior ii) above).
Fig. 3. The IFLs have the ability to filter light in the visible spectrum. Transmission
schematic (A) for setup with fibre coupled white light source into a collimating lens (L1),
iris and PDMS filtering lens (LPDMS). There is an additional lens to focus the light into
a second optical fibre (L2) feeding to the fibre coupled spectrometer. (B) % transmission
spectra measured by the spectrometer for the green IFLs (labelled G) and red 1% IFLs
(labelled R) over the visible spectrum. (C) Transmission spectra for green IFLs 1% to 10%.
The green IFLs show a concentration dependent response with 10% lens blocking more light
than the 1% IFLs across the spectrum. Transmission peak at 545 nm displaying the IFLs
ability to transmit green light. (D) Optical density plot for the filtering lens showing that the
higher doped IFLs had a greater optical density than the lower doped IFLs.
On the contrary, the higher doped IFLs filter out a higher percentage of light towards the blue
end of the spectrum. Commonly, fluorescence emission is red shifted away from the excitation
wavelength, which means that the higher doped IFLs have a better ability to block the incident
light (described as behavior i) above). However, the higher doped IFLs also act at a greater
optical density across the full visible spectrum as shown in Fig. 3(D). The lower doped IFLs
allow for a greater amount of the emitted wavelength light to pass through.
The lenses that were more effective in blocking the incident light were less effective at
transmitting shifted light and vice versa. This means that a balance between these characteristics
needs to be sought.
The PDMS IFLs are appropriate for use with a fluorophore that emits in the green region
of the visible spectrum above 520 nm and is excited by wavelengths < 470 nm, with the 10%
IFLs giving the highest potential excitation blocking to emission transmission ratio. However,
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imaging with the various IFLs concluded that 3% doping balances the filtering effects with the
light source power requirement, as shown in Fig. 4.
Fig. 4. The filtering PDMS IFLs are able to image fluorescent targets with a resolution
of 3 µm, including labelled M. smegmatis on a OnePlus 5 T smartphone. (A) Schematic
of the smartphone microscope setup with IFL attached directly to the camera lens, with a
glass slide bearing fluorescently labelled sample illuminated by a white LED light source.
(B) Smartphone with PDMS IFL on the front camera imaging USAF targets. Top, left-
right: positive USAF 1951 target Group 6 imaged with 25 µL IFLs at 0%, 1% and 3%.
Resolution achieved is 4.4 µm. Bottom, left-right: positive USAF 1951 target Group 6
imaged with 10 µL IFLs at 0%, 1% and 3% IFL. Resolution achieved is 3.1 µm, scale bar
shows 5 µm. (C) Representative imaging of fluorescently labelledM. smegmatis captured
with the smartphone with either 0% or 3% doped IFL (digital zoom 1.8x or 8x) or wide-field
fluorescent microscope (20x objective). All images shown to scale with full FOV captured.
Scale bar shows 250 µm. (D) Fluorescent images shown in (C) scaled to show the same size
FOV for comparison of image quality taken from the same location at 1.8 x zoom (left) and
8x zoom (right). Scale bar shows 100 µm.
3.3. Imaging with the PDMS integrated filtering lenses
The PDMS IFLs were combined with a OnePlus 5 T smartphone running android 9, as shown in
Fig. 4(A), to build an imaging system that could have an application at the POC. The specifications
for the camera used for imaging were 16 MP and f= 20mm, sensor 1/3.1 with a pixel size of
1 µm. The PDMS IFLs are self-adhesive to the camera on the phone.
Whilst Mtb characteristically appears as clumps of cells during sputum-smear microscopy, the
average size of a single Mtb is 2 - 4 µM, therefore it is desirable for frugal imaging systems to have
a resolution within this region. Using the 1951 USAF target (R1DS1P, Thorlabs) it was possible
to determine the resolution of the 25 µL lens system to be less than 4 µm as shown in Fig. 4(B).
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The 10 µL IFLs have a greater resolution, at 3.1 µm, but the IFL is smaller than the smartphone
camera and physical application of the IFL is more challenging than with the 25 µL IFLs. As
discussed above, the 25 µL IFLs give a greater FOV which is beneficial when imaging over a
greater area. These images were obtained using a white LED. Further work should investigate
the most appropriate light source, including a blue LED with a fluorescent target.
The doping of the lenses impacted the required LED power to form an image. At a concentration
of 1% or 3% dopant there was a sufficient filtering effect to remove light outside of the excitation
spectrum, whilst allowing an image to form. Above this, the optical density was too great as it
fully removed the required excitation light. Whilst we were able to obtain these high resolution
images of the USAF target, we do observe noise within the images; these are jpeg compression
artefacts; they are most prevalent at the high digital zoom levels which are required to display
these images, and limits optical resolution.
Fluorescently labelled M. smegmatis was imaged with clear and 3% doped lenses by our
IFL-smartphone microscopy platform. The M. smegmatis was labelled directly on the slide with
a wash-free fluorescent SmartProbe, which enables the labelling of microbes within seconds. The
images were compared with benchtop wide-field microscopy images of the same slides collected
at 20x magnification. Figure 4(C) demonstrates the functional utility of developing doped lenses,
despite imaging the same specimen with the same set-up no fluorescently labelled M. smegmatis
are visible when using the clear lenses, that is compared to very distinct fluorescent puncta visible
when the 3% IFL is used within the set-up. Moreover the field-of-view is on the order of 1 mm2
meaning that the operator would need to scan fewer fields compared to conventional fluorescence
microscopy, and potentially false-negatives resultant from diffuse samples, or samples with low
bacterial load (as is often the case for sputum smear microscopy of Mtb) could be reduced. Whilst
we were able to achieve a much larger field-of-view with our smartphone setup at both 1.8x and
8x camera zoom compared to conventional wide-field fluorescence microscopy, we did not suffer
from significant loss in resolution from our device. Figure 4(D) shows the same size field-of-view
for each imaging set-up, and clumps of M. smegmatis of various sizes are easily distinguishable.
Due to the low pathogenicity, but similar cell-wall structure and morphology of M. smegmatis to
M. tuberculosis it is widely accepted as an in vitro model for the latter [33], thus it was selected
as the model organism within this study, and we anticipate that similar fluorescence intensity and
resolution could be achieved in subsequent TB imaging studies, however this warrants further
biological evaluation.
4. Conclusion
We demonstrated here a potential application towards fluorescently labelled TB detection, which
requires only the confirmation of the presence of the bacterial species, not benchtop microscope
resolution of the microbe. As such, a TB screening IFL device could be realized with only
a phone and a green dye doped IFL. The PDMS IFLs described here were able to combine
two optical components, a lens and a filter, into a single low-cost solution that could be used
at the POC. These lenses have a simple manufacturing protocol that can be easily scaled up
for a cost of < 0.02 USD pp, with mass production ensuring control over contact angle and
hence the focal length. This would ensure that smartphones with different camera specifications
can be catered for with minimal IFL modification. In addition, a large number of fluorescent
dyes exist, each with a variety of optical properties which could be leveraged to produce IFLs
suitable for an array of diagnostic applications; and although beyond the scope of this work, 3D
printed microscope stages are available open source and could add to the utility of a complete
IFL-enabled smartphone microscope platform. In this way, we envision that the IFLs presented
here will be suitable for a number of POC diagnostic applications, with the IFLs themselves
being easily transportable and robust, adhering to ASSURED criteria [34].
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The IFLs were combined with smartphone cameras, and whilst these require some energy,
solar powered chargers are widely available or can be charged from a generator. Furthermore,
applying the IFLs requires little training for non-skilled technicians to obtain an image, meaning a
health care worker in a rural village could use them at the POC, store the data and then connect to
hospitals or clinics with the results remotely. Whilst the pigment doping will only be compatible
with certain fluorophores, this will be of advantage in a system designed to only detect one
specific label, such as a specific stain for TB.
We focused here on green IFLs because the majority of fluorescent labels are in the green
spectral range, like the nitrobenzoxadiazole (NBD) conjugated stain used in the imaging above.
Although lenses with a variety of spectral filtering behaviours have been recently developed, the
application here is specific for the POC [26]. In choosing the correct doping, a balance between
the spectral filtering behaviours of blocking out incident light and transmitting emitted light is
key, and the 3% doping was found to be adequate. Further work should investigate the red IFLs
as this would increase the possible fluorescent labels that could be coupled into the system. The
25 µL IFLs offer a balance between FOV and resolution. They are easier to handle than the 10 µL
lens and therefore maybe better suited to in-field applications.
One of the ongoing concerns in translating smartphone technology to the POC is the preparation
of slides or biopsy. Currently there is limited advantage in progressing imaging capabilities while
processing and fixation remains a barrier in the field. Future work into POC devices needs to
address this concern if POC testing is to achieve its full potential in the future. Using ‘smart’,
wash-free fluorescent labels, as demonstrated here, negates the need for multiple processing
steps and may make this possible. Similarly, we captured all of the smartphone images using
the camera’s automatic color balancing function, further demonstrating the ease of use of this
imaging setup.
It is not purely a lack of technology that limits the implementation of POC devices in rural
LMICs. In reality, the lack of consensus on procedure and definitions (despite national policy
regarding contact tracing) continues to hamper progress [35] and so a multifaceted approach to
engage leaders and experts will be needed for any POC device. Our vision is that the PDMS
IFLs could be used in POC devices that use any smartphone with a camera app to enable in-field
diagnostics. Such a device may have significant utility in settings such as POC sputum smear
microscopy for TB, where accurately recording the presence or absence of the bacterium is
paramount, particularly from diffuse samples or samples with low bacterial load. Evaluation
of how our novel imaging platform performs on clinical sputum specimens from TB patients
remains to be seen and offers an exciting continuation of study.
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